The ASAM Review Course in Addiction Medicine 2017

The ASAM Review Course in Addiction Medicine is widely recognized as the essential primer for physicians and clinicians preparing for a career in addiction medicine, as well as for primary care providers who wish to increase their skills in identifying and managing patients whose medical problems are caused or exacerbated by substance use disorders.

The course offers two and a half days of sessions which are mapped to the addiction medicine exam blueprint of topics for the exam and features an outstanding faculty. Over 800 professionals attend this popular course each time it is offered. ASAM’s Review Course has had a major impact on advancing a common base of scientific knowledge among physicians and other healthcare professionals.

Learning Objectives:

Upon completion, participants should be able to:

  • Demonstrate practical knowledge on the neurobiology of addiction and articulate its activity in terms useful in a clinical setting
  • Describe the effects of alcohol, tobacco and other drugs in both tolerant and non-tolerant individuals
  • Describe the process for diagnosing addiction and differentiating the symptoms of addiction from those of other medical or psychiatric disorders
  • Explain the various pharmacologic and psychosocial treatments for addictive disorders and describe the factors that should be considered in selecting a treatment modality to match the needs of a specific patient
  • Describe the precipitants of relapse and current evidence-based practices to prevent and manage relapse


 

  • Evaluation and Certificate - 2017 Review Course

    Contains 2 Component(s), Medical Credits Offered

    This is the CME Evaluation for attendees of the 2017 Review Course.

    This is the CME Evaluation for attendees of the 2017 Review Course.

  • Session 1: Alcohol (1 CME)

    Contains 4 Component(s), Medical Credits Offered

    Experts in the field discuss aspects of Alcohol likely to appear on the 2017 ABPM Certification Exam for Addiction Medicine.

    The Following Topics are addressed in this session:

    • Alcohol
    • Pharmacological Interventions for Alcohol Dependence
    • Management of Alcohol Intoxication and Withdrawal

    Ricardo Restrepo

    MD, MPH

    Ricardo Restrepo Guzman M.D.,M.P.H finished his medical school in Medellfn,Colombia. He did his residency training In Psychiatry at Boston University Medical Center and completed a fellowship in Addiction Psychiatry at the same institution. He received a Master's degree in Global Public Health from New York University in 2008, while working at St Luke's Roosevelt Hospital Center, an academic institution affiliated with Columbia University,where he was the Director of the Addiction Psychopharmacology Clinic at the Addiction Institute of New York,as well as Attending Psychiatrist at the Adult Outpatient Clinic. He remains affiliated with the Addiction Institute of New York as a faculty member. In 2012 he started to work at the Long Beach VA Hospital, where he is the Medical Director of the Substance Abuse Treatment Program/Buprenorphlne Clinic as well as an Attending Psychiatrist at the Department of Mental Health. Ricardo holds an academic position as Assistant Clinical Professor of Psychiatry and Human Behavior at the University of California Irvine School of Medicine. He teaches and supervises students,psychiatry,family medicine residents and staff at the Long Beach VA Hospital and works with the diverse population of Los Angeles and Orange Counties. His academic interests include the psychotherapy and psychopharmacology of addiction,the teaching of Psychiatry and Addiction Medicine around the United States and other countries. He is actively involved in issues related to transcultural psychiatry,human rights, and behavioral addictions. Ricardo has worked with immigrant populations in the United States for over 15 years. He is also a volunteer physician for Physicians for Human Rights (PHR}. He has conducted medical evaluations and clinical treatment of people who have survived torture and other forms of abuse,and has served as a United Nations Consultant since 2005. Ricardo writes monthly for the Colombian healthcare newspaper "EJ Pulso", among other publications in the medical field. He has written chapters for addiction and human rights textbooks. He Is the co-author of texbooks on buprenorphine as well as women's health and addiction. Most recently Ricardo cooperate with the APA/ DSM-5 Translation to Spanish language. He is board certified in Psychiatry and Addiction Psychiatry.

  • Session 2: Sedatives (.75 CME)

    Contains 3 Component(s), Medical Credits Offered

    Experts in the field discuss aspects of Sedatives likely to appear on the 2017 ABPM Certification Exam for Addiction Medicine.

    The Following Topics are addressed in this session:

    • Benzodiazepines, Benzodiazepine Receptor Agonists, Barbiturates and Other Sedative-Hypnotics
    • GHB
    • General Principles in Management of Intoxication and Withdrawal
    • Management of Sedative-Hypnotic Intoxication and Withdrawal

    Ricardo Restrepo

    MD, MPH

    Ricardo Restrepo Guzman M.D.,M.P.H finished his medical school in Medellfn,Colombia. He did his residency training In Psychiatry at Boston University Medical Center and completed a fellowship in Addiction Psychiatry at the same institution. He received a Master's degree in Global Public Health from New York University in 2008, while working at St Luke's Roosevelt Hospital Center, an academic institution affiliated with Columbia University,where he was the Director of the Addiction Psychopharmacology Clinic at the Addiction Institute of New York,as well as Attending Psychiatrist at the Adult Outpatient Clinic. He remains affiliated with the Addiction Institute of New York as a faculty member. In 2012 he started to work at the Long Beach VA Hospital, where he is the Medical Director of the Substance Abuse Treatment Program/Buprenorphlne Clinic as well as an Attending Psychiatrist at the Department of Mental Health. Ricardo holds an academic position as Assistant Clinical Professor of Psychiatry and Human Behavior at the University of California Irvine School of Medicine. He teaches and supervises students,psychiatry,family medicine residents and staff at the Long Beach VA Hospital and works with the diverse population of Los Angeles and Orange Counties. His academic interests include the psychotherapy and psychopharmacology of addiction,the teaching of Psychiatry and Addiction Medicine around the United States and other countries. He is actively involved in issues related to transcultural psychiatry,human rights, and behavioral addictions. Ricardo has worked with immigrant populations in the United States for over 15 years. He is also a volunteer physician for Physicians for Human Rights (PHR}. He has conducted medical evaluations and clinical treatment of people who have survived torture and other forms of abuse,and has served as a United Nations Consultant since 2005. Ricardo writes monthly for the Colombian healthcare newspaper "EJ Pulso", among other publications in the medical field. He has written chapters for addiction and human rights textbooks. He Is the co-author of texbooks on buprenorphine as well as women's health and addiction. Most recently Ricardo cooperate with the APA/ DSM-5 Translation to Spanish language. He is board certified in Psychiatry and Addiction Psychiatry.

  • Session 3: Opioids (.75 CME)

    Contains 3 Component(s), Medical Credits Offered

    Experts in the field discuss aspects of Opioids likely to appear on the 2017 ABPM Certification Exam for Addiction Medicine.

    The Following Topics are addressed in this session:

    • Opioids (Opium, Heroin, Prescription Opioids)
    • Management of Opioid Intoxication and Withdrawal
    • Pharmacological Interventions for Opioid Dependence

    Edwin A. Salsitz

    MD, DFASAM

    Dr. Edwin A. Salsitz has been an attending physician at Mount Sinai Beth Israel, Department of Psychiatry and Behavioral Sciences, since 1983, and is an Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai.  He is the principal investigator of the Methadone Medical Maintenance (office-based methadone maintenance) research project.  Dr. Salsitz is certified by the American Board of Addiction Medicine (ABAM), as well as by the Board of Internal Medicine and Pulmonary Disease.  He  lectures frequently and has been published on a variety of addiction medicine topics.

    Dr. Salsitz is a course director for ASAM sponsored buprenorphine trainings, and is a mentor in the PCSS-MAT and PCSS-O mentoring programs. He has co-chaired  the ASAM Review Course, the ASAM Common Threads Course, the ASAM State of the Art Course and  is a reviewer for the Journal of Addiction Medicine. Currently Dr. Salsitz is the chair of the ASAM REMS ER/LA Opioids committee. Dr. Salsitz is a member of the ASAM CME committee and Chair of the New York Society of Addiction Medicine CME and Education committee. He is the recipient of the 2014 ASAM Annual AwardDr. Salsitz is a member of the Medical Advisory Panel, for the New York State Office of Alcohol and Substance Abuse Services.

  • Session 4: Tobacco (.75 CME)

    Contains 3 Component(s), Medical Credits Offered

    Experts in the field discuss aspects of Tobacco likely to appear on the 2017 ABPM Certification Exam for Addiction Medicine.

    The Following Topics are addressed in this session:

    • Nicotine and Tobacco
    • Management of Other Drug Intoxication and Withdrawal (Nicotine)
    • Pharmacological Interventions for Tobacco Dependence

    Abigail J. Herron

    DO, DFASAM

    Abigail J. Herron, DO, is the Director of Psychiatry and the Director of the Fellowship in Addiction Medicine at the Institute for Family Health.  She is board certified in adult psychiatry, addiction psychiatry and addiction medicine, and is an Assistant Professor of Psychiatry at the Icahn School of Medicine at Mt. Sinai.  Dr. Herron is a fellow of the American Psychiatric Association and a Distinguished Fellow of the American Society of Addiction Medicine.  She graduated from Wesleyan University and the University of Medicine and Dentistry of New Jersey School of Osteopathic Medicine.  Dr. Herron completed her psychiatry residency at St. Luke's and Roosevelt Hospitals, where she was also chief resident, and a clinical research fellowship in addiction psychiatry at Columbia University and the New York State Psychiatric Institute.  Her academic interests include integrated care, women’s health, and medical education.  She is the co-editor of the Addiction Casebook, and the editor-in-chief of ASAM’s Essentials of Addiction Medicine.  Dr. Herron is also in private practice in New York City. 

  • Session 5: Cannabis (.75 CME)

    Contains 3 Component(s), Medical Credits Offered

    Experts in the field discuss aspects of Cannabis likely to appear on the 2017 ABPM Certification Exam for Addiction Medicine.

    The Following Topics are addressed in this session:

    • Cannabinoids
    • Management of Other Drug Intoxication and Withdrawal (Cannabinoids)

    Carla Marienfeld

    MD

    Carla Marienfeld, MD, is an addiction psychiatrist and an Associate Clinical Professor of Psychiatry at University of California San Diego.  Clinically, she focuses on the treatment of patients with substance use disorders and co-morbid psychiatric conditions.  She previously worked at a large outpatient addiction treatment program serving over 5000 patients.  Her academic interests focus on implementation research and large-data health outcomes for patients with substance use disorders.  She attended Baylor College of Medicine in Houston, TX, where she completed the International Health Track, served nationally on the Board of Trustees of the American Medical Student Association (AMSA), and earned Alpha Omega Alpha (AOA) Medical Honors Society and Honors distinction.  During psychiatry residency at Yale, she served as chief resident, a National Institute of Drug Abuse R25 Research Fellow, and as the resident representative to the Accreditation Council for Graduate Medical Education (ACGME), while also earning several awards and fellowships.  She completed a fellowship in Addiction Psychiatry at Yale.  During residency and her early faculty years, she founded and led the Yale Global Mental Health Program.  She served as the site training director for the Yale New Haven Hospital Addiction Psychiatry Fellowship and supervised and taught medical students for psychiatry, residents for global mental health, and fellows for addiction psychiatry.  She has come to UCSD to help in the development and implementation of a new Addiction Recovery and Treatment Program. 

  • Session 6: Stimulants (.75 CME)

    Contains 3 Component(s), Medical Credits Offered

    Experts in the field discuss aspects of Stimulants likely to appear on the 2017 ABPM Certification Exam for Addiction Medicine.

    The Following Topics are addressed in this session:

    • Cocaine, Amphetamine and Other Stimulants
    • MDMA
    • Management of Other Drug Intoxication and Withdrawal (Cocaine, Stimulants)

    Petros Levounis

    MD, MA, DFASAM

    Petros Levounis, MD, MA, is Chair of the Department of Psychiatry at Rutgers-New Jersey Medical School and Chief of Psychiatry at the University Hospital in Newark, New Jersey. Dr. Levounis came to Rutgers from Columbia University where he served as Director of the Addiction Institute of New York and Chief of Addiction Psychiatry at St. Luke's and Roosevelt Hospitals from 2002 to 2013. Dr. Levounis is board-certified in Psychiatry, Addiction Psychiatry, and Addiction Medicine. His academic interests include the psychotherapy and psychopharmacology of addiction and co-occurring psychiatric disorders, the teaching of Psychiatry, gay and lesbian mental health, and the behavioral addictions.

  • Session 7: Other Classes of Drugs (.75 CME)

    Contains 3 Component(s), Medical Credits Offered

    Experts in the field discuss aspects of Other Classes of Drugs likely to appear on the 2017 ABPM Certification Exam for Addiction Medicine.

    The Following Topics are addressed in this session:

    • Hallucinogens (LSD, Mescaline, Psilocybin, and Other Hallucinogens)
    • Dissociatives (Phencyclidine, Ketamine, Dextromethorphan and Other Dissociatives)
    • Inhalants (Nitrous Oxide, Hydrocarbons and Other Inhalants)
    • Anabolic Steroids
    • Management of Other Drug Intoxication and Withdrawal (Phencyclidine, Hallucinogens, Dissociatives, Inhalants, Steroids
    • Pharmacologic Interventions for Other Drug Dependence
    • Pharmacological Interventions for Non-Substance Related Addictions

    Erin A. Zerbo

    MD

    Erin Zerbo, MD, is an Assistant Professor in the Department of Psychiatry at Rutgers New Jersey Medical School, and the Associate Director of Medical Student Education. She will serve as Director of the Wellness Center at University Hospital when it opens in Fall 2015.

    She received her B.S. in Brain and Cognitive Sciences from the Massachusetts Institute of Technology in 2003, and her M.D. from New York University School of Medicine in 2007. She continued in a psychiatry residency at New York University, where she served as chief resident during her PGY-IV year and received the Harold I. Kaplan Memorial Award for excellence in teaching and the Wendy Rives Memorial Award for compassion in working with the severely mentally ill. Following residency, she remained at NYU for a one-year fellowship in Addiction Psychiatry.

    Prior to her faculty position at Rutgers, Dr. Zerbo served as the Associate Director of the Consultation-Liaison Psychiatry Service at Bellevue Hospital and the Associate Director of the NYU Addiction Psychiatry fellowship.

    Dr. Zerbo's primary interest has always been the treatment of addiction in the context of public psychiatry. She is especially interested in the pharmacotherapy of substance use disorders among underserved populations, and in addressing systemic barriers to integrated and continuous care. Recent publications include a chapter entitled “Co-occurring Personality Disorders and Addiction" in The ASAM Principles of Addiction Medicine textbook, and an article accepted for publication in the Harvard Review of Psychiatry which explores how to improve attitudes of psychiatry residents toward patients with substance use disorders.

  • Session 8: Behavioral Addictions (.75 CME)

    Contains 3 Component(s), Medical Credits Offered

    Experts in the field discuss aspects of Behavioral Addictions likely to appear on the 2017 ABPM Certification Exam for Addiction Medicine.

    The Following Topics are addressed in this session:

    • Non-substance Addictions: Gambling, Sex, Food
    • Pharmacological Interventions for Non-Substance Related Addictions

    Erin A. Zerbo

    MD

    Erin Zerbo, MD, is an Assistant Professor in the Department of Psychiatry at Rutgers New Jersey Medical School, and the Associate Director of Medical Student Education. She will serve as Director of the Wellness Center at University Hospital when it opens in Fall 2015.

    She received her B.S. in Brain and Cognitive Sciences from the Massachusetts Institute of Technology in 2003, and her M.D. from New York University School of Medicine in 2007. She continued in a psychiatry residency at New York University, where she served as chief resident during her PGY-IV year and received the Harold I. Kaplan Memorial Award for excellence in teaching and the Wendy Rives Memorial Award for compassion in working with the severely mentally ill. Following residency, she remained at NYU for a one-year fellowship in Addiction Psychiatry.

    Prior to her faculty position at Rutgers, Dr. Zerbo served as the Associate Director of the Consultation-Liaison Psychiatry Service at Bellevue Hospital and the Associate Director of the NYU Addiction Psychiatry fellowship.

    Dr. Zerbo's primary interest has always been the treatment of addiction in the context of public psychiatry. She is especially interested in the pharmacotherapy of substance use disorders among underserved populations, and in addressing systemic barriers to integrated and continuous care. Recent publications include a chapter entitled “Co-occurring Personality Disorders and Addiction" in The ASAM Principles of Addiction Medicine textbook, and an article accepted for publication in the Harvard Review of Psychiatry which explores how to improve attitudes of psychiatry residents toward patients with substance use disorders.

  • Session 9: History of Addiction Treatment (.75 CME)

    Contains 3 Component(s), Medical Credits Offered

    Experts in the field discuss aspects of The History of Addiction Treatment likely to appear on the 2017 ABPM Certification Exam for Addiction Medicine.

    The Following Topics are addressed in this session:

    • History of Addiction Medicine
    • Treatment of Alcohol Use Disorders
    • Treatment of Drug Use Disorders
    • Linking Addiction Treatment With Other Medical and Psychiatric Treatment
    • Alternative Therapies for Alcohol and Drug Addiction
    • Non-Substance Addictions: Gambling, Sex, Food
    • Treatment Needs of Children and Adolescents
    • Treatment Needs of Seniors
    • Quality Management in Addiction Treatment

    Paul H. Earley

    MD, DFASAM

    Dr. Earley has been an Addiction Medicine Physician for 30 years. He treats all types of addictive disorders and specializes in the assessment and treatment of health care professionals. As a therapist, he works with patients already in recovery, providing long term therapy for those who suffer from this disease.  His professional expertise extends to advocacy for professionals before agencies and licensing boards. 
    Dr. Earley is a dynamic speaker and educator; he speaks and trains on topics of addiction, its treatment and addiction among health care professionals. In addition, he trains therapists about the neurobiological basis of psychotherapy. In his travels, he has provided training in the United States, Canada, the United Kingdom, Italy and Switzerland. 
    He is the author of two books and numerous articles on addiction and its treatment. He is a contributing author to the American Society of Addiction Medicine (ASAM) Textbook: Principles of Addiction Medicine, as author of the chapter: Physician Health Programs and Addiction among Physicians.  He is a contributing author to the ASAM Criteria. His most recent book RecoveryMind Training is published by Central Recovery Press. 
    His work was featured in the documentary series on addiction entitled Close to Home by Bill Moyers. Dr. Earley is a Fellow of ASAM and has been on the board of ASAM for over 14 years in several capacities and is currently a director-at-large. He has been the Medical Director of two nationally acclaimed addiction programs specializing in the care of addicted health care professionals. Currently, Dr. Earley is the Medical Director of the Georgia Professionals Health Program, Inc., the Physicians Health Program (PHP) for the state of Georgia in the U.S. With Earley Consultancy, LLC, he works with numerous treatment facilities, providing training in cohesive care, treatment effectiveness and staff development.
    Dr. Earley is the recipient of the ASAM Annual Award in 2015. ASAM states the award is presented “For outstanding contributions to the growth and vitality of our Society, for thoughtful leadership in the field, and for deep understanding of the art and science of Addiction Medicine” and “For expanding the frontiers of the field of Addiction Medicine and broadening our understanding of the addictive process, through research and innovation.”

The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

The ASAM CME Committee and Reviewers Disclosure Listing

Name

Commercial Interest

What was received?

For what role?

Adam J. Gordon, MD, MPH, FACP, DFASAM, CMRO, Chair

None

 

 

Catherine Friedman, MD

Vice Chair

None

 

  

Noel Ilogu, MD, MRCP, DFASAM

None

 

 

Hebert L. Malinoff, MD, FACP, DFASAM

None

 

 

Edwin A. Salsitz, MD, DFASAM

None

 

 

John C. Tanner, DO, DABAM, DFASAM, CCFC, MRO

Indivior

BDSI

Honorarium

Honorarium

Speaker

Consultant/Speaker

 

The ASAM Review Course Program Planning Committee Disclosure Listing

Name

Commercial Interest

What was received?

For what role?

Petros Levounis, MD, MD, DFASAM

None

 

 

Abigail Herron, DO, DFASAM, FAPA

None

 

 

Timothy K. Brennan, MD, MPH, FASAM

None

 

 

David Galbis-Reig, MD, DFASAM

Abbot Pharmaceuticals

 

AbbVie

 

 

Cortex Pharmaceuticals

 

GW Pharmaceuticals

 

Hospira

 

 

Pfizer, INC

Ownership Interest

 

Ownership Interest

 

Ownership Interest

 

Ownership Interest

 

Ownership Interest

 

Ownership Interest

Stock Options

 

 

Stock Options

(spouse)

 

Stock Owned through IRA Rollover Account

Stock Owned through IRA Rollover Account

Stock Options

(Spouse)

 

Bonds in IRA

Carla Marienfield, MD

None

 

 

Ricardo Restrepo, MD, MPH

None

 

 

Edwin A. Salsitz, MD, DFASAM

None

 

 

Erin Zerbo, MD

None

 

 

 

The ASAM Review Course Faculty Member Disclosure Listing

Name

Commercial Interest

What was received?

For what role?

Petros Levounis, MD, MD, DFASAM

None

 

 

Abigail Herron, DO, DFASAM, FAPA

None

 

 

Timothy K. Brennan, MD, MPH, FASAM

None

 

 

Jeffrey DeVido, MD, MTS

Philip Morris

 

 

Altria

Ownership Interest

 

Ownership Interest

Equity Shareholder

 

Equity Shareholder

Paul H. Earley, MD, DFASAM

Alkermes

 

Georgia PHP, INC

 

Earley Counsultancy, LLC

 

DynamiCare Health, INC

Honoraria

 

Salary

 

 

Salary

 

 

 

Salary

Speaker

 

Medical Director

 

 

Principal

 

 

 

Speaker

James W. Finch, MD, DFASAM

Orexo Pharmaceuticals

 

Indivior Pharmaceuticals

Honoraria

 

 

Honoraria

Speaker

 

 

Speaker

Marc Fishman, MD, DFASAM

Alkermes

 

 

US WorldMeds

 

 

 

 

MediaRez

Salary

 

 

Salary

 

 

 

 

Research Funding

Consultant; Advisory Board

 

Consultant; Advisory Board; Principal Research Investigator

 

Principal Research Investigator

David Galbis-Reig, MD, DFASAM

Abbot Pharmaceuticals

 

AbbVie

 

 

Cortex Pharmaceuticals

GW Pharmaceuticals

 

Hospira

 

 

Pfizer, Inc

Ownership Interest

 

Ownership Interest

 

Ownership Interest

Ownership Interest

 

Ownership Interest

 

Ownership Interest

Stock Options

 

 

Stock Options

(spouse)

Stock Owned through IRA Rollover Account

Stock Owned through IRA

 

Rollover Account

Stock Options

(Spouse)

Bonds in IRA

Leslie Hayes, MD

None

 

 

Carla Marienfield, MD

None

 

 

Ricardo Restrepo, MD, MPH

None

 

 

Richard Ries, MD, DFASAM

None

 

 

Edwin A. Salsitz, MD, DFASAM

None

 

 

Sharon Stancliff, MD

None

 

 

Timothy J. Wiegand, MD, FACMT, FAACT, FASAM

None

 

 

Erin Zerbo, MD

None

 

 

ACCME Accreditation Statement:

The American Society of Addiction Medicine is accredited by the Accreditation Council for
Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement:

The American Society of Addiction Medicine designates this live activity for a maximum of 20.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Academy of Family Physicians: 

This Live activity, The 2017 ASAM Review Course in Addiction Medicine & Pre-Courses, with a beginning date of 07/26/2017, has been reviewed and is acceptable for up to 27.50 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABAM Transitional Maintenance of Certification Program (Tmoc)

This course has been approved by The American Board of Addiction Medicine (ABAM).  Physicians enrolled in the Transitional Maintenance of Certification (Tmoc) Program can apply a maximum of 20.5 AMA PRA Category 1 Credits

Upon completion, participants should be able to:

  • Demonstrate practical knowledge on the neurobiology of addiction and articulate its activity in terms useful in a clinical setting
  • Describe the effects of alcohol, tobacco and other drugs in both tolerant and non-tolerant individuals
  • Describe the process for diagnosing addiction and differentiating the symptoms of addiction from those of other medical or psychiatric disorders
  • Explain the various pharmacologic and psychosocial treatments for addictive disorders and describe the factors that should be considered in selecting a treatment modality to match the needs of a specific patient
  • Describe the precipitants of relapse and current evidence-based practices to prevent and manage relapse

The ASAM Review Course in Addiction Medicine provides an up-to-date review of the core content of addiction medicine for:

  • Physicians preparing for the ABPM Board Certification/Recertification Examination in addiction medicine
  • Addiction specialists seeking a "refresher" course that incorporates recent developments in addiction science and practice
  • Non-specialist physicians and other healthcare professionals needing the knowledge to identify and manage problems related to substance use disorders for their patients